Microorganism of Corynebacterium genus having enhanced L-arginine or L-citrulline productivity and a method for producing L-arginine or L-citrulline using the same

US12486490B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12486490-B2
Application numberUS-202217937833-A
CountryUS
Kind codeB2
Filing dateOct 4, 2022
Priority dateJul 21, 2022
Publication dateDec 2, 2025
Grant dateDec 2, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present disclosure relates to a Corynebacterium sp. mutant strain having increased L-arginine or L-citrulline productivity and a method of producing L-arginine or L-citrulline using the same. The Corynebacterium sp. mutant strain has enhanced activity of acetylornithine aminotransferase involved in the L-arginine biosynthesis pathway, and thus is capable of producing L-arginine or L-citrulline productivity in an increased yield compared to a parent strain.

First claim

Opening claim text (preview).

What is claimed is: 1 . A Corynebacterium sp. mutant strain having increased L-arginine or L-citrulline productivity by having enhanced activity of acetylornithine aminotransferase, wherein said acetylornithine aminotransferase has a substitution of threonine for alanine at amino acid position 131 in the amino acid sequence of SEQ ID NO: 2. 2 . The Corynebacterium sp. mutant strain of claim 1 , which is Corynebacterium glutamicum. 3 . A method for producing L-arginine or L-citrulline comprising steps of: culturing the Corynebacterium sp. mutant strain of claim 1 in a medium; and recovering L-arginine or L-citrulline from the cultured mutant strain or the medium in which the mutant strain has been cultured.

Assignees

Inventors

Classifications

  • Corynebacterium · CPC title

  • Acetylornithine transaminase (2.6.1.11) · CPC title

  • Citrulline; Arginine; Ornithine · CPC title

  • C12N9/1096Primary

    transferring nitrogenous groups (2.6) · CPC title

  • for Corynebacterium; for Brevibacterium · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12486490B2 cover?
The present disclosure relates to a Corynebacterium sp. mutant strain having increased L-arginine or L-citrulline productivity and a method of producing L-arginine or L-citrulline using the same. The Corynebacterium sp. mutant strain has enhanced activity of acetylornithine aminotransferase involved in the L-arginine biosynthesis pathway, and thus is capable of producing L-arginine or L-cit…
Who is the assignee on this patent?
Daesang Corp
What technology area does this patent fall under?
Primary CPC classification C12N9/1096. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Dec 02 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).